Evidence mapPaperPMID 41929903Full record

ReviewFrontiers in public health2026

Shifting sands in Saudi Arabian healthcare system towards value-based care: navigating the changing landscape.

Ahmed Al-Jedai, Hajer Almudaiheem, Wejdan Ibrahim Said Aburas, Eid Almutairi, Maysa Tariq Eshmawi, Khalid Al Sulaiman, Essam Tawfik, Mohammed Al-Luhidan, Mohammad Alowairdhi, Nancy Awad and 2 more

Abstract readReview
In one paragraph

Review in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ahmed Al-JedaiColleges of Medicine and Pharmacy, Alfaisal University, Riyadh, Saudi Arabia.
Hajer AlmudaiheemClinical Pharmacy, The Saudi Society of Clinical Pharmacy, Riyadh, Saudi Arabia.
Wejdan Ibrahim Said AburasMinistry of Health, Riyadh, Saudi Arabia.
Eid AlmutairiKing Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Maysa Tariq EshmawiCollege of Medicine, Imam Mohammed Ibn Saud Islamic University, Riyadh, Saudi Arabia.
Khalid Al SulaimanKing Abdulaziz Medical City, Riyadh, Saudi Arabia.
Essam TawfikKing Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia.
Mohammed Al-LuhidanSaudi Health Council, Riyadh, Saudi Arabia.
Mohammad AlowairdhiSaudi Food and Drug Authority, Riyadh, Saudi Arabia.
Nancy AwadPharmaceutical Sciences, Carexso, Dubai, United Arab Emirates.
Rita OjeilLife Sciences Solution, PDC-CRO, Dubai, United Arab Emirates.
Mohammed Ahmed AlshennawiMinistry of Health, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The KSA's healthcare system is undergoing substantial transformation under Vision 2030, with a strategic shift toward value-based healthcare (VBHC). This perspective paper examines the national reform initiatives and implementation readiness using five interrelated domains: data interoperability and governance, health technology assessment (HTA) capacity and availability of local data, policy fragmentation across high-cost therapeutic areas, operational burden of managed entry and risk-sharing agreements, and equity and stakeholder trust. Evidence was synthesized from peer-reviewed literature, policy documents, and institutional sources from the Saudi Ministry of Health. The analysis highlights progress in digital health integration, formulary modernization, pharmacoeconomic evaluation, real-world data infrastructure, and expanding use of value-linked reimbursement mechanisms. However, persistent challenges include fragmented digital systems, limited technical capacity for advanced HTA, heterogeneous policy implementation in specialized therapeutic areas, administrative complexity associated with performance-based agreements, and ongoing equity and trust considerations. Emerging methodological advances, including cost-effectiveness thresholds, development of multi-criteria decision analysis frameworks, and establishment of a Saudi-specific EQ-5D-5L valuation, strengthen the foundation for VBHC implementation. In this paper, we have recommended an implementation-oriented assessment of system enablers and constraints and identifies priority areas to support scalable, evidence-based, and sustainable adoption of VBHC in the KSA.

Indexed as

Delivery of Health CareHealth Care ReformValue-Based Health CareCost-Benefit AnalysisDigital HealthHealth PolicyHumansSaudi ArabiaTechnology Assessment, Biomedicalhealth technology assessmentsKingdom of Saudi Arabiapublic-private partnershipSaudi Ministry of HealthSaudi Vision 2030value-based healthcare

Identifiers

PMID41929903
PMCPMC13038946

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.